CRH from OPCs times myelin repair after injury, offering mechanism for Alzheimer's white-matter loss
CRH release by OPCs after brain injury acts as a temporal regulator of remyelination; its disruption produces more progenitors but fewer functional oligodendrocytes. The same receptor is present during normal development and may be perturbed in Alzheimer's myelin pathology, suggesting a shared checkpoint amenable to targeted intervention.
Because CRHR1 is already expressed on OPCs during postnatal myelination, the pathway likely operates across both developmental and injury contexts. Pharmacological titration of CRHR1 signaling in aged AD mouse models could therefore test whether restoring the transient brake improves myelin thickness and cognitive performance, a direct translational step the original injury-focused study left unexplored.
Deussing: Selective CRHR1 agonism in 12-month 5xFAD mice will increase corpus-callosum myelin thickness by ≥15% versus vehicle within 8 weeks, measured by electron microscopy.
Sources (2)
- [1]Primary Source(https://www.cell.com/cell-reports/fulltext/S2211-1247(26)01044-3)
- [2]Supporting Source(https://www.nature.com/articles/s41593-023-01482-9)